Skip to main content
Lifecare ASA logo

Lifecare ASA — Investor Relations & Filings

Ticker · LIFE ISIN · NO0013355859 LEI · 254900D88MYGZ7JD5P39 OL Manufacturing
Open in API
Filings indexed 809 across all filing types
Latest filing 2026-02-25 Board/Management Inform…
Country NO Norway
Listing OL LIFE

About Lifecare ASA

https://lifecare.no/

Lifecare ASA is a clinical-stage medical sensor company specializing in the development of nanotechnology for medical applications. Its core activity involves creating miniaturized, implantable, and long-term nanobiosensors for the continuous monitoring of various body analytes. The company's primary focus is on developing a sensor for correct and continuous glucose monitoring to improve diabetes management. The business model is based on developing and licensing its proprietary sensor technology to facilitate the production and sale of advanced medical devices.

Recent filings

Filing Released Lang Actions
Lifecare ASA appoints Petter Nielsen as Chief Financial Officer - Attachment: Lifecare ASA appoints Petter Nielsen as Chief Financial Officer.pdf
Board/Management Information Classification · 1% confidence The document is an official announcement regarding the appointment of a new Chief Financial Officer (Petter Nielsen) and the departure of the current CFO (Renete Kaarvik) at Lifecare ASA. This falls directly under the category of management changes, which is defined as Board/Management Information (MANG).
2026-02-25 English
Lifecare ASA appoints Petter Nielsen as Chief Financial Officer
Board/Management Information Classification · 1% confidence The document is an official announcement regarding the appointment of a new Chief Financial Officer (Petter Nielsen) and the departure of the outgoing CFO (Renete Kaarvik) at Lifecare ASA. This falls directly under the category of changes in senior management.
2026-02-25 English
Lifecare signs EU Declaration of Conformity for implant electronics - Attachment: Lifecare signs EU Declaration of Conformity for implant electronics.pdf
Regulatory Filings Classification · 1% confidence The document is a press release from Lifecare ASA announcing the signing of an EU Declaration of Conformity for their implant electronics. It describes a regulatory milestone in the CE marking process. Since it is a general corporate announcement regarding regulatory compliance and product development status that does not fit into specific categories like financial reports, dividends, or M&A, it is best classified as a general regulatory filing.
2026-02-23 English
Lifecare signs EU Declaration of Conformity for implant electronics
Regulatory Filings Classification · 1% confidence The document is a short press release (2559 characters) announcing that Lifecare ASA has signed an EU Declaration of Conformity for its implant electronics. It does not contain financial statements, proxy materials, or other specific report types defined in the schema. As it is a general corporate announcement regarding regulatory compliance and product development milestones, it falls under the 'Regulatory Filings' (RNS) category as the fallback for miscellaneous corporate announcements.
2026-02-23 English
Lifecare receives notification of intended grant in European patent application and provides update on IP strategy - Attachment: Lifecare receives notification of intended grant in European patent app
Investor Presentation Classification · 1% confidence The document is a press release from Lifecare ASA announcing the receipt of a notification regarding an intended patent grant from the European Patent Office and providing an update on the company's intellectual property (IP) strategy. It does not fit into financial reporting categories like 10-K, IR, or ER, nor does it relate to dividends, board changes, or legal proceedings. As it is a general corporate announcement regarding business operations and strategy that does not fall into the other specific categories, it is best classified as a Regulatory Filing (RNS).
2026-02-19 English
Lifecare receives notification of intended grant in European patent application and provides update on IP strategy
Investor Presentation Classification · 1% confidence The document is a corporate announcement regarding the status of a patent application and an update on the company's intellectual property (IP) strategy. It does not fit into financial reporting categories like 10-K, ER, or IR, nor does it relate to dividends, board changes, or share transactions. As it is a general regulatory announcement regarding company operations and strategy that does not fall into the other specific categories, it is best classified as a general regulatory filing.
2026-02-19 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.